Clinical Trials for United Therapeutics

Explore 20 clinical trials worldwide

Showing 1-20 of 20 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: United Therapeutics

Clinical Trials (20)

NCT07116681
Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension
EARLY_PHASE1Not yet recruiting
8 participants
Started: Oct 1, 2025 · Completed: Jul 1, 2027
1 condition2 sponsors0 locations
NCT07037836
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
PHASE1Recruiting
10 participants
Started: Sep 29, 2025 · Completed: Jul 1, 2027
2 conditions2 sponsors1 location
NCT06878560
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2075
3 conditions1 sponsor1 location
NCT06911632
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NARecruiting
1,000 participants
Started: Jul 23, 2025 · Completed: Jul 31, 2028
2 conditions2 sponsors11 locations
NCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/ARecruiting
1,000 participants
Started: Jan 23, 2025 · Completed: Nov 30, 2030
3 conditions1 sponsor34 locations
NCT06450041
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
PHASE2Active, not recruiting
62 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2038
1 condition4 sponsors13 locations
NCT06477640
Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NARecruiting
55 participants
Started: Jul 29, 2024 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT05943535
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
PHASE3Recruiting
698 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2027
2 conditions1 sponsor138 locations
NCT05776225
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
N/ARecruiting
300 participants
Started: Aug 11, 2023 · Completed: Feb 28, 2026
2 conditions1 sponsor42 locations
NCT05421897
Rapid Administration Pilot for Infusing Dinutuximab
PHASE1Recruiting
11 participants
Started: Nov 29, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05203510
A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
PHASE4Active, not recruiting
52 participants
Started: Oct 20, 2022 · Completed: Apr 30, 2028
1 condition2 sponsors28 locations
NCT04905693
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
PHASE3Enrolling by invitation
1,850 participants
Started: Sep 6, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor187 locations
NCT04708782
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
PHASE3Active, not recruiting
576 participants
Started: Jun 1, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor99 locations
NCT04005469
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
PHASE1/PHASE2Recruiting
20 participants
Started: Nov 13, 2020 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT03814317
Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
PHASE2Recruiting
10 participants
Started: Jan 30, 2020 · Completed: Jul 29, 2026
3 conditions2 sponsors1 location
NCT03683186
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
PHASE3Enrolling by invitation
1,000 participants
Started: Sep 23, 2019 · Completed: Dec 31, 2026
11 conditions1 sponsor209 locations
NCT02573896
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
PHASE1Active, not recruiting
13 participants
Started: Jan 14, 2019 · Completed: Sep 30, 2025
1 condition3 sponsors11 locations
NCT03626688
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
PHASE3Active, not recruiting
1,000 participants
Started: Aug 30, 2018 · Completed: Dec 31, 2025
11 conditions1 sponsor209 locations
NCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
N/AActive, not recruiting
300 participants
Started: Jul 18, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor41 locations
NCT01321073
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NAActive, not recruiting
64 participants
Started: Jun 30, 2011 · Completed: Dec 31, 2032
1 condition2 sponsors8 locations